Rossi Christina 4
4 · Blueprint Medicines Corp · Filed May 7, 2025
Insider Transaction Report
Form 4
Rossi Christina
CHIEF OPERATING OFFICER
Transactions
- Sale
Common Stock
2025-05-05$101.77/sh−1,343$136,677→ 67,316 total - Sale
Common Stock
2025-05-05$102.82/sh−180$18,508→ 67,136 total - Sale
Common Stock
2025-05-05$100.97/sh−607$61,289→ 68,659 total - Sale
Common Stock
2025-05-05$103.56/sh−144$14,913→ 66,992 total
Footnotes (5)
- [F1]Effected pursuant to a trading plan adopted on August 27, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $100.32 to $101.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $101.33 to $102.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $102.34 to $103.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $103.35 to $104.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.